The role and challenges of intratumoral microbiota in colorectal cancer immunotherapy
Frontiers in Pharmacology · 07.08.2025 · 16
DOI: 10.3389/fphar.2025.1634703 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.08.2025. Verfasst von Miao Hao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Research Center, China-Japan Union Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Colorectal cancer (CRC) is the third most common malignant tumor globally, and its development is closely related to interactions between the host and microbes. Recent studies have shown that the diversity of intratumoral microbiota significantly influences CRC progression and responses to immune therapy. This influence occurs through mechanisms such as immune microenvironment regulation, metabolic reprogramming, and epigenetic modifications. However, there is still a lack of systematic analysis regarding the diversity of intratumoral microbiota in CRC and its immune regulatory mechanisms, particularly in the metabolic and immune regulation. This article presents a systematic review of the compositional characteristics of intratumoral microbiota in CRC, the associated immune regulatory mechanisms, and their roles in chemotherapy and immunotherapy. It also discusses challenges like standardizing microbiome detection methods and the ethics of clinical translation, while proposing a strategy for integrating multi-omics using artificial intelligence. This article provides a theoretical basis for developing personalized treatment regimens that target the microbiota.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Scientific Research Center, China-Japan Union Hospital of Jilin University, Changchun, China.
- Department of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, China.
- Department of Respiratory and Critical Care Medicine, China-Japan Union Hospital of Jilin University, Changchun, China.
- Department of Ultrasound, China-Japan Union Hospital of Jilin University, Changchun, China.
Zitieren
APA
Hao, M., Xu, H., Li, M., & Jiao, D. (2025). The role and challenges of intratumoral microbiota in colorectal cancer immunotherapy. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1634703
Vancouver
Hao M, Xu H, Li M, Jiao D. The role and challenges of intratumoral microbiota in colorectal cancer immunotherapy. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1634703
BibTeX
@article{Hao2025,
author = {Hao, Miao and Xu, Haiming and Li, Min and Jiao, Dan},
title = {The role and challenges of intratumoral microbiota in colorectal cancer immunotherapy},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1634703}
}
EUVIMED